MA38169A1 - Ciclésonide pour le traitement d'une maladie des voies respiratoires chez les chevaux - Google Patents
Ciclésonide pour le traitement d'une maladie des voies respiratoires chez les chevauxInfo
- Publication number
- MA38169A1 MA38169A1 MA38169A MA38169A MA38169A1 MA 38169 A1 MA38169 A1 MA 38169A1 MA 38169 A MA38169 A MA 38169A MA 38169 A MA38169 A MA 38169A MA 38169 A1 MA38169 A1 MA 38169A1
- Authority
- MA
- Morocco
- Prior art keywords
- ciclesonide
- horses
- treatment
- respiratory tract
- disease
- Prior art date
Links
- LUKZNWIVRBCLON-GXOBDPJESA-N Ciclesonide Chemical compound C1([C@H]2O[C@@]3([C@H](O2)C[C@@H]2[C@@]3(C[C@H](O)[C@@H]3[C@@]4(C)C=CC(=O)C=C4CC[C@H]32)C)C(=O)COC(=O)C(C)C)CCCCC1 LUKZNWIVRBCLON-GXOBDPJESA-N 0.000 title abstract 2
- 208000018569 Respiratory Tract disease Diseases 0.000 title abstract 2
- 229960003728 ciclesonide Drugs 0.000 title abstract 2
- 239000003814 drug Substances 0.000 abstract 2
- 208000019693 Lung disease Diseases 0.000 abstract 1
- 208000011623 Obstructive Lung disease Diseases 0.000 abstract 1
- 239000003862 glucocorticoid Substances 0.000 abstract 1
- 230000002757 inflammatory effect Effects 0.000 abstract 1
- 230000037361 pathway Effects 0.000 abstract 1
- 230000000306 recurrent effect Effects 0.000 abstract 1
- 230000000241 respiratory effect Effects 0.000 abstract 1
- 208000023504 respiratory system disease Diseases 0.000 abstract 1
- 229940037128 systemic glucocorticoids Drugs 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/0078—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a nebulizer such as a jet nebulizer, ultrasonic nebulizer, e.g. in the form of aqueous drug solutions or dispersions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Pulmonology (AREA)
- Otolaryngology (AREA)
- Dispersion Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
- Medicinal Preparation (AREA)
Abstract
L'invention concerne le domaine de la médecine, en particulier le domaine de la médecine vétérinaire. La présente invention concerne des glucocorticoïdes, en particulier le ciclésonide ou un dérivé pharmaceutiquement acceptable de celui-ci, pour le traitement d'une maladie des voies respiratoires chez les chevaux, telles qu'une maladie pulmonaire, de préférence l'obstruction récurrente des voies respiratoires (rao), la maladie pulmonaire obstructive associée aux pâturages d'été (spaopd), et une maladie inflammatoire des voies respiratoires (iad).
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP12199302 | 2012-12-21 | ||
| PCT/EP2013/077265 WO2014096115A1 (fr) | 2012-12-21 | 2013-12-18 | Ciclésonide pour le traitement d'une maladie des voies respiratoires chez les chevaux |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| MA38169A1 true MA38169A1 (fr) | 2017-01-31 |
| MA38169B2 MA38169B2 (fr) | 2021-08-31 |
Family
ID=47552829
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MA38169A MA38169B2 (fr) | 2012-12-21 | 2013-12-18 | Ciclésonide pour le traitement d'une maladie des voies respiratoires chez les chevaux |
Country Status (24)
| Country | Link |
|---|---|
| US (4) | US20140179651A1 (fr) |
| EP (1) | EP2934479B1 (fr) |
| AR (1) | AR094241A1 (fr) |
| AU (2) | AU2013360691B2 (fr) |
| BR (2) | BR112015010842B1 (fr) |
| CA (1) | CA2888428C (fr) |
| CY (2) | CY1121115T1 (fr) |
| DK (1) | DK2934479T3 (fr) |
| ES (1) | ES2693779T3 (fr) |
| FR (1) | FR20C1026I1 (fr) |
| HR (1) | HRP20181980T1 (fr) |
| HU (1) | HUS2000020I1 (fr) |
| IN (1) | IN2015DN02894A (fr) |
| LT (2) | LT2934479T (fr) |
| MA (1) | MA38169B2 (fr) |
| MX (1) | MX368306B (fr) |
| NO (1) | NO2020014I1 (fr) |
| NZ (1) | NZ706573A (fr) |
| PL (1) | PL2934479T3 (fr) |
| PT (1) | PT2934479T (fr) |
| RS (1) | RS57740B1 (fr) |
| SI (1) | SI2934479T1 (fr) |
| WO (1) | WO2014096115A1 (fr) |
| ZA (1) | ZA201502288B (fr) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AR089645A1 (es) | 2011-08-12 | 2014-09-10 | Boehringer Ingelheim Vetmed | Particula multicapas de sabor enmascarado, metodo, uso, composicion farmaceutica |
| ES2909039T3 (es) | 2012-12-21 | 2022-05-05 | Boehringer Ingelheim Vetmedica Gmbh | Formulación farmacéutica que comprende ciclesonida |
| IN2015DN02894A (fr) | 2012-12-21 | 2015-09-11 | Boehringer Ingelheim Vetmed | |
| AU2015276310B2 (en) | 2014-06-18 | 2020-01-16 | Boehringer Ingelheim Vetmedica Gmbh | Muscarinic antagonists and combinations thereof for the treatment of airway disease in horses |
| KR102035478B1 (ko) * | 2016-10-14 | 2019-10-23 | 제주대학교 산학협력단 | 시클레소나이드를 포함하는, 암 줄기세포 성장 억제용 조성물 |
| WO2021140113A1 (fr) * | 2020-01-10 | 2021-07-15 | Boehringer Ingelheim Vetmedica Gmbh | Ciclésonide pour améliorer la qualité de vie (qol) chez les équidés |
| FI4188327T3 (fi) | 2020-07-31 | 2025-07-25 | Chemo Res S L | Yhdistelmähoito inhalaatioannosteluun |
Family Cites Families (31)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5954049A (en) | 1991-10-15 | 1999-09-21 | Trudell Medical Limited | Equine mask with MDI adapter |
| DE19536902A1 (de) | 1995-10-04 | 1997-04-10 | Boehringer Ingelheim Int | Vorrichtung zur Hochdruckerzeugung in einem Fluid in Miniaturausführung |
| US5823179A (en) | 1996-02-13 | 1998-10-20 | 1263152 Ontario Inc. | Nebulizer apparatus and method |
| US6264923B1 (en) * | 1998-05-13 | 2001-07-24 | 3M Innovative Properties Company | Medicinal aerosol formulation of ciclesonide and related compounds |
| US6706726B2 (en) | 2000-10-14 | 2004-03-16 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Anticholinergics which may be used as medicaments as well as processes for preparing them |
| DE10050994A1 (de) | 2000-10-14 | 2002-04-18 | Boehringer Ingelheim Pharma | Neue als Arneimittel einsetzbare Anticholinergika sowie Verfahren zu deren Herstellung |
| DE10062712A1 (de) | 2000-12-15 | 2002-06-20 | Boehringer Ingelheim Pharma | Neue Arzneimittelkompositionen auf der Basis von Anticholinergika und Corticosteroiden |
| US6904908B2 (en) | 2002-05-21 | 2005-06-14 | Trudell Medical International | Visual indicator for an aerosol medication delivery apparatus and system |
| DE10237739A1 (de) | 2002-08-17 | 2004-02-26 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Inhalative Arzneimittel enthaltend ein neues Anticholinergikum in Kombination mit Corticosteroiden und Betamimetika |
| US7244742B2 (en) | 2002-08-17 | 2007-07-17 | Boehringer Ingelheim Pharma Gmbh & Co Kg | Pharmaceutical compositions for inhalation containing an anticholinergic, corticosteroid and betamimetic |
| AU2003272450A1 (en) | 2002-09-13 | 2004-04-30 | C. Steven Smith | Novel composition and method for treatment of upper respiratory conditions |
| US20060293293A1 (en) * | 2003-05-22 | 2006-12-28 | Altana Pharma Ag | Salmeterol and ciclesonide combination |
| US20050020692A1 (en) | 2003-07-24 | 2005-01-27 | Ciofalo Vincent B. | Treatment of heaves |
| EP1670482B2 (fr) | 2003-09-16 | 2022-06-29 | Covis Pharma B.V. | Utilisation de ciclesonide dans le traitement de maladies respiratoires |
| PE20050941A1 (es) * | 2003-12-16 | 2005-11-08 | Nycomed Gmbh | Suspensiones acuosas de ciclesonida para nebulizacion |
| US20070134165A1 (en) | 2004-04-20 | 2007-06-14 | Altana Pharma Ag | Use of Ciclesonide for the Treatment of Respiratory Disease in a Smoking Patient |
| WO2006003078A1 (fr) | 2004-06-29 | 2006-01-12 | Boehringer Ingelheim International Gmbh | Medicaments pour inhalation comprenant des steroides et un anticholinergique |
| DE102004056579A1 (de) | 2004-11-23 | 2006-05-24 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Inhalative Arzneimittel enthaltend ein neues Anticholinergikum, Salmeterol und ein Steroid |
| UY30542A1 (es) | 2006-08-18 | 2008-03-31 | Boehringer Ingelheim Int | Formulacion de aerosol para la inhalacion de agonistas beta |
| UY30543A1 (es) | 2006-08-18 | 2008-03-31 | Boehringer Ingelheim Int | Formulacion de aerosol para la inhalacion de beta- agonistas |
| US8815258B2 (en) | 2009-05-29 | 2014-08-26 | Pearl Therapeutics, Inc. | Compositions, methods and systems for respiratory delivery of two or more active agents |
| WO2010149280A1 (fr) | 2009-06-25 | 2010-12-29 | Boehringer Ingelheim Vetmedica Gmbh | Inhalateur |
| US7829748B1 (en) | 2009-09-21 | 2010-11-09 | Honeywell International Inc. | Process for the manufacture of 1,3,3,3-tetrafluoropropene |
| WO2014007766A1 (fr) | 2012-07-05 | 2014-01-09 | Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi | Inhalateurs de poudre sèche comprenant un excipient autre que le lactose |
| EA201590030A1 (ru) | 2012-07-05 | 2015-09-30 | Арвен Айлак Санайи Ве Тиджарет А.С. | Ингаляторы сухого порошка, содержащие носитель, отличный от лактозы, и третий компонент |
| US9539408B2 (en) | 2012-10-31 | 2017-01-10 | Trudell Medical International | Nebulizer apparatus |
| IN2015DN02894A (fr) | 2012-12-21 | 2015-09-11 | Boehringer Ingelheim Vetmed | |
| ES2909039T3 (es) | 2012-12-21 | 2022-05-05 | Boehringer Ingelheim Vetmedica Gmbh | Formulación farmacéutica que comprende ciclesonida |
| WO2015024651A1 (fr) | 2013-08-20 | 2015-02-26 | Boehringer Ingelheim Vetmedica Gmbh | Inhalateur |
| MX377423B (es) | 2013-08-20 | 2025-03-10 | Boehringer Ingelheim Vetmedica Gmbh | Inhalador. |
| AU2015276310B2 (en) | 2014-06-18 | 2020-01-16 | Boehringer Ingelheim Vetmedica Gmbh | Muscarinic antagonists and combinations thereof for the treatment of airway disease in horses |
-
2013
- 2013-12-18 IN IN2894DEN2015 patent/IN2015DN02894A/en unknown
- 2013-12-18 US US14/132,580 patent/US20140179651A1/en not_active Abandoned
- 2013-12-18 LT LTEP13811924.3T patent/LT2934479T/lt unknown
- 2013-12-18 WO PCT/EP2013/077265 patent/WO2014096115A1/fr not_active Ceased
- 2013-12-18 EP EP13811924.3A patent/EP2934479B1/fr active Active
- 2013-12-18 ES ES13811924.3T patent/ES2693779T3/es active Active
- 2013-12-18 HR HRP20181980TT patent/HRP20181980T1/hr unknown
- 2013-12-18 RS RS20181190A patent/RS57740B1/sr unknown
- 2013-12-18 DK DK13811924.3T patent/DK2934479T3/en active
- 2013-12-18 NZ NZ70657313A patent/NZ706573A/en unknown
- 2013-12-18 MX MX2015007947A patent/MX368306B/es active IP Right Grant
- 2013-12-18 US US14/654,009 patent/US9918995B2/en active Active
- 2013-12-18 PT PT13811924T patent/PT2934479T/pt unknown
- 2013-12-18 SI SI201331266T patent/SI2934479T1/sl unknown
- 2013-12-18 AU AU2013360691A patent/AU2013360691B2/en active Active
- 2013-12-18 PL PL13811924T patent/PL2934479T3/pl unknown
- 2013-12-18 MA MA38169A patent/MA38169B2/fr unknown
- 2013-12-18 CA CA2888428A patent/CA2888428C/fr active Active
- 2013-12-18 BR BR112015010842-3A patent/BR112015010842B1/pt active IP Right Grant
- 2013-12-18 BR BR122016029247-9A patent/BR122016029247A2/pt not_active Application Discontinuation
- 2013-12-20 AR ARP130104978A patent/AR094241A1/es not_active Application Discontinuation
-
2015
- 2015-04-07 ZA ZA2015/02288A patent/ZA201502288B/en unknown
-
2016
- 2016-10-13 US US15/292,765 patent/US10258634B2/en active Active
-
2018
- 2018-02-06 US US15/889,307 patent/US10441597B2/en active Active
- 2018-03-07 AU AU2018201642A patent/AU2018201642B2/en active Active
- 2018-11-09 CY CY181101189T patent/CY1121115T1/el unknown
-
2020
- 2020-06-12 NO NO2020014C patent/NO2020014I1/no unknown
- 2020-06-18 LT LTPA2020511C patent/LTPA2020511I1/lt unknown
- 2020-06-26 FR FR20C1026C patent/FR20C1026I1/fr active Active
- 2020-06-29 CY CY2020015C patent/CY2020015I2/el unknown
- 2020-06-29 HU HUS2000020C patent/HUS2000020I1/hu unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MA38169A1 (fr) | Ciclésonide pour le traitement d'une maladie des voies respiratoires chez les chevaux | |
| EA031157B9 (ru) | Вводимая перорально кортикостероидная композиция | |
| EA201270221A1 (ru) | Лечение болезни крона с применением лаквинимода | |
| EP2582676A4 (fr) | Modulateurs allostériques positifs du récepteur m1 de l'amide tétrahydroquinoline | |
| EA201290519A1 (ru) | Положительные аллостерические модуляторы рецептора хинолин амида m1 | |
| PH12017500444A1 (en) | Pharmaceutical compositions comprising a dextromethorphan compound and quinidine for the treatment of agitation in dementia | |
| NZ625592A (en) | Compositions and methods for the treatment of hepatic diseases and disorders | |
| PH12016500746B1 (en) | A novel formulation of meloxicam | |
| EA201001781A1 (ru) | Применение гликозаминогликанов для перорального введения и композиции гликозаминогликанов | |
| MX2019014935A (es) | Antagonistas muscarinicos y sus combinaciones para el tratamiento de enfermedades de las vias respiratorias en caballos. | |
| EA201390070A1 (ru) | Лечение расстройств, вызванных l-dopa, дофаминовым агонистом и/или усилителем дофамина | |
| RU2016132762A (ru) | Фармацевтические композиции, содержащие 15-гэпк, и способы лечения астмы и заболеваний легких с их применением | |
| MX350662B (es) | Composiciones farmaceuticas que comprenden 7- (1h- imidazol-4-ilmetil) -5,6,7,8,-tetrahidroquinolina para el tratamiento de enfermedades y dolencias de la piel. | |
| EP2239257A4 (fr) | Nouveau dérivé de quinazoline-2,4-dione et compositions médicales pour la prophylaxie et le traitement de la maladie du nerf crânien contenant ledit dérivé | |
| EP2431049A4 (fr) | Préparation pharmaceutique destinée à être administrée dans des organes respiratoires pour le traitement ou la prévention de maladies respiratoires inflammatoires, et procédé de traitement ou de prévention de telles maladies | |
| PH12015502560B1 (en) | Use of a thiazolo pyrimidinone for the treatment of inflammatory bowel disease | |
| PH12016501119A1 (en) | Zirconium silicate for treating hyperkalemia without co-administering lithium | |
| FR2927256B1 (fr) | Composition pour le traitement des affections inflammatoires des voies respiratoires a base d'une alfa-amylase et d'un anesthesique local et son procede de preparation | |
| Wollin et al. | PI3kinase Gamma Kinase Dead Knock-In Mice Are Protected Against Cigarette Smoke-Induced Pulmonary Inflammation | |
| FR2960780B1 (fr) | Medicament pour le traitement de la maladie de parkinson | |
| JO2919B1 (en) | Aryl methyl benzocoinazolinone M1 positive allosteric modulation receptor | |
| UA111587C2 (uk) | Сполуки для лікування захворювань, пов'язаних з амілоїдними або амілоїдоподібними білками |